+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease



Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease



Ocular Surface 14(1): 2-19



The intent of this review is to comprehensively appraise the state of the art with regard to Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), with particular attention to the ocular surface complications and their management. SJS and TEN represent two ends of a spectrum of immune-mediated, dermatobullous disease, characterized in the acute phase by a febrile illness followed by skin and mucous membrane necrosis and detachment. The widespread keratinocyte death seen in SJS/TEN is rapid and irreversible, and even with early and aggressive intervention, morbidity is severe and mortality not uncommon. We have divided this review into two parts. Part I summarizes the epidemiology and immunopathogenesis of SJS/TEN and discusses systemic therapy and its possible benefits. We hope this review will help the ophthalmologist better understand the mechanisms of disease in SJS/TEN and enhance their care of patients with this complex and often debilitating disease. Part II (April 2016 issue) will focus on ophthalmic manifestations.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905142

Download citation: RISBibTeXText

PMID: 26549248

DOI: 10.1016/j.jtos.2015.10.002


Related references

Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocular Surface 14(2): 168-188, 2016

Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases. Revista Medica de Chile 137(3): 383-389, 2010

Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis. Nederlands Tijdschrift Voor Geneeskunde 140(30): 1538-1543, 1996

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a systemic review. Journal of Dermatological Treatment 2019: 1-25, 2019

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatology 153(6): 514-522, 2017

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Advances in Therapy 34(6): 1235-1244, 2017

Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy. Seminars in Ophthalmology 31(1-2): 178-187, 2016

Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis syndrome in patients undergoing radiation therapy: a literature review. American Journal of Clinical Oncology 37(5): 506-513, 2014

Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Critical Care Medicine 39(6): 1521-1532, 2011

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review. Revista Da Associacao Medica Brasileira 62(5): 468-473, 2017

Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome. Balkan Medical Journal 29(3): 310-313, 2012

Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus. Journal of the American Academy of Dermatology 13(4): 665-666, 1985

Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysis. Journal of Clinical Rheumatology 20(3): 167-171, 2014

A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis. International Journal of Dermatology 54(1): E18-E26, 2015

Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome. Bratislavske Lekarske Listy 112(5): 260-263, 2011